BioForm (BFRM) Posts Q2 EPS of $0.03, Beats by 2c
BioForm Medical, Inc. (NASDAQ: BFRM) reports Q2 EPS of $0.03, 2 cents better than the analyst estimate of $0.01. Revenue for the quarter was $21.79 million, which compares to the estimate of $18.65 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Toro Co. (TTC) Tops Q1 EPS by 13c; Guides FY12 EPS Above Views; to Split Stock
- AFC Enterprises, Inc. (AFCE) Tops Q1 EPS by 4c; Raises FY12 Comps Outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
